SHAREHOLDERS EQUITY (Details 2) - Warrants |
6 Months Ended |
|---|---|
|
Jun. 30, 2026
$ / shares
shares
| |
| Outstanding, beginning of period | shares | 868,130 |
| Outstanding, end of period | shares | 868,130 |
| Weighted average exercise price outstanding, Beginning balance | $ 6.96 |
| Weighted average exercise price, Granted | 0 |
| Weighted average exercise price, Exercised | 0 |
| Weighted average exercise price, Expired | 0 |
| Weighted average exercise price outstanding, Ending balance | $ 6.96 |
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their stock options into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|